Evidence map›Paper›PMID 24413774›Full record

ArticleNature immunology2014

STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling.

Andreas Begitt, Mathias Droescher, Thomas Meyer, Christoph D Schmid, Michelle Baker, Filipa Antunes, Klaus-Peter Knobeloch, Markus R Owen, Ronald Naumann, Thomas Decker and 1 more

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Prohibitions in the meta-inflammatory response: a review.Frontiers in molecular biosciences · 2024
    Review
  10. Strategies to therapeutically modulate cytokine action.Nature reviews. Drug discovery · 2023
    Review
  11. Article
  12. Article
  13. 3CVirologica Sinica · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Stochastic dynamics of Type-I interferon responses.PLoS computational biology · 2022
    Article
  18. Article
  19. Myofibroblast transcriptome indicates SFRP2Nature communications · 2021
    Article
  20. Study of the Active Components and Molecular Mechanism ofFrontiers in molecular biosciences · 2021
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Andreas Begitt1] School of Life Sciences, University of Nottingham, Nottingham, UK. [2].
Mathias Droescher1] School of Life Sciences, University of Nottingham, Nottingham, UK. [2] [3].
Thomas Meyer1] Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Germany. [2].
Christoph D Schmid1] Swiss Tropical and Public Health Institute, Basel, Switzerland. [2] Universität Basel, Basel, Switzerland.
Michelle BakerCentre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK.
Filipa Antunes1] School of Life Sciences, University of Nottingham, Nottingham, UK. [2].
Klaus-Peter Knobeloch
Markus R OwenCentre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK.
Ronald NaumannMax-Planck-Institut für molekulare Zellbiologie und Genetik, Dresden, Germany.
Thomas DeckerDepartment für Mikrobiologie und Immunbiologie, Universität Wien, Wien, Austria.
Uwe VinkemeierSchool of Life Sciences, University of Nottingham, Nottingham, UK.
University of Nottingham · GBMax Planck Institute of Molecular Cell Biology and Genetics · DEMax Planck Society · DESwiss Tropical and Public Health Institute · CHUniversitätsmedizin Göttingen · DEUniversity Medical Center Freiburg · DEUniversity of Vienna · AT

Funding

Biotechnology and Biological Sciences Research Council BB/G019290/1Biotechnology and Biological Sciences Research Council BB/I532353/1Medical Research Council MR/L001276/1Wellcome Trust
6 · The paper itself

Abstract

STAT1 is an indispensable component of a heterotrimer (ISGF3) and a STAT1 homodimer (GAF) that function as transcription regulators in type 1 and type 2 interferon signaling, respectively. To investigate the importance of STAT1-cooperative DNA binding, we generated gene-targeted mice expressing cooperativity-deficient STAT1 with alanine substituted for Phe77. Neither ISGF3 nor GAF bound DNA cooperatively in the STAT1F77A mouse strain, but type 1 and type 2 interferon responses were affected differently. Type 2 interferon-mediated transcription and antibacterial immunity essentially disappeared owing to defective promoter recruitment of GAF. In contrast, STAT1 recruitment to ISGF3 binding sites and type 1 interferon-dependent responses, including antiviral protection, remained intact. We conclude that STAT1 cooperativity is essential for its biological activity and underlies the cellular responses to type 2, but not type 1 interferon.

Indexed as

AnimalsCells, CulturedDNAInterferon-gammaInterferon-Stimulated Gene Factor 3Interferon Type IListeriosisMiceMice, Inbred C57BLMice, TransgenicMutant ProteinsProtein BindingProtein EngineeringSignal TransductionSTAT1 Transcription FactorTransgenesDNAInterferon-gammaInterferon-Stimulated Gene Factor 3Interferon Type IMutant ProteinsSTAT1 Transcription Factor

Identifiers

PMID24413774
OpenAlexW2067211313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.